chr1-235755570-T-G
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000081.4(LYST):c.7137A>C(p.Leu2379Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0355 in 1,613,120 control chromosomes in the GnomAD database, including 1,238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000081.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- Chediak-Higashi syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- attenuated Chédiak-Higashi syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0287 AC: 4371AN: 152150Hom.: 98 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0345 AC: 8675AN: 251358 AF XY: 0.0332 show subpopulations
GnomAD4 exome AF: 0.0362 AC: 52860AN: 1460852Hom.: 1140 Cov.: 31 AF XY: 0.0357 AC XY: 25972AN XY: 726852 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0287 AC: 4375AN: 152268Hom.: 98 Cov.: 32 AF XY: 0.0291 AC XY: 2167AN XY: 74452 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3Other:1
- -
- -
- -
Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
not specified Benign:3
- -
- -
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Chédiak-Higashi syndrome Benign:2
- -
- -
Autoinflammatory syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at